Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: the first multicentre, phase III trial in China

BACKGROUND AND PURPOSE: Data on the efficacy and safety of alteplase for acute ischaemic stroke (AIS) administered 3–4.5 hours after the onset of stroke symptoms in Chinese patients is limited. We sought to determine whether AIS patients would benefit from thrombolysis with alteplase between 3 and 4...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Stroke Vasc Neurol
Autori principali: Zheng, Huaguang, Yang, Yi, Chen, Huisheng, Li, Chuanling, Chen, Yangkun, Shi, Fu-Dong, Yang, Li, Cui, Xiaoping, Lu, Zuneng, Liang, Yanling, Cui, Songbiao, Xu, Anding, Wu, Yiqing, Sun, Yaqing, Wang, Yongjun
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2020
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7548519/
https://ncbi.nlm.nih.gov/pubmed/32467323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/svn-2020-000337
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi